<?xml version="1.0" encoding="UTF-8"?>
<!-- This is a template for a FHIR resource, and needs items (marked with "${}") replacing to make a real instance -->
<!-- The resulting instance is a Bundle of Bundles, each of which is a document (having a Composition, and supporting resources) -->
<!-- 2020-02-22 -->
<!-- This is for FHIR version R5 Preview 2 (May 2020) -->
<Bundle xmlns="http://hl7.org/fhir">
	<type value="collection"/>
	<!-- Repeat at this level per document -->
	<entry>
		<fullUrl value="urn:uuid:814e81a1-b1d8-479e-b2dd-cdce4c37cdd7"/>
		<!-- Top level of each document is a also FHIR Bundle, of type "document"
		 see http://hl7.org/fhir/documents.html, http://hl7.org/fhir/bundle.html
	 	 All the other resources for this document are within this. -->
		<resource>
            <Bundle>
            	<!-- When PUTing, some servers mandate an id here to match the existing id -->
            	<id value="670742d5-55d8-4024-a3e0-36feca33c472"/>
				<!-- document bundles must have an identifier (bdl-9) -->
				<identifier>
					<!-- possibly different identifier types may be needed here -->
					<system value="http://ema.europa.eu/fhir/identifier/documentid"/>
					<value value="${instance.bundle[n].Identifier}"/>
				</identifier>
				<!-- fixed code -->
				<type value="document" /> 
            	<!-- document bundles must have a date (bdl-10) -->
            	<timestamp value="2021-05-07T13:18:08Z"/>
				<!-- a repeating set of entry elements, each with a FHIR resource inside -->
				<entry>
					<!-- fullUrl is mandatory for each entry in document Bundle. It is a random uuid. http://build.fhir.org/bundle.html#bundle-unique -->
					<fullUrl value="urn:uuid:ac5263b5-879d-4faf-8941-09101ae5ad67"/>
					<resource>
						<!-- the first resource must be Composition (bdl-11) -->
						<!-- This is the overall document structure. -->
						<!-- see definition http://hl7.org/fhir/composition.html, and similar for other resources -->
                        <Composition>
                        	<!-- images if requied within html text of this document -->
							
							<status value="final"/>
							<!-- document type -->
							<type>
								<coding>
									<system value="http://spor.ema.europa.eu/v1/lists/100000155531"/>
									<code value="${document[n].documentTypeCode}"/>
									<display value="${document[n].documentTypeDisplay}"/>
								</coding>
							</type>
							<subject>
								<!-- links to the List resource in this bundle - local url format -->
								<reference value="[]"/> <!-- local url format -->
								<!--reference value="${instance.bundle[n].listUuid}"/--> <!-- uuid url format. Possible alternate format may be neeed -->
							</subject>
                        	<!-- mandatory date of the document -->
                        	<date value="2021-02-01"/>
							<author>
								<identifier>
									<system value="http://spor.ema.europa.eu/v1/locations" />
									<value value="" />
								</identifier>
							</author>
                        	<title value="${document[n].title}"/>
							<relatesTo>
								<code value="appends"/>
								<targetReference>
									<!-- reference to another Composition -->
									<reference value="${document[n].relatesTo}"/>
								</targetReference>
							</relatesTo>
							<!-- main sections of the document, to follow the QRD template -->
	               			
<section>
	
		
			<title value="ANNEX II"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:70.8pt;line-height:normal"></p>
			</div>
		</text>
		
		
    	    
				
			    
						
		               
<section>
			<title value="A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="C.      OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:77.9pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="D.      conditions or restrictions with regard to the safe and effective use of the medicinal PRODUCT"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:70.8pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="E.      SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
	
		
		
    	    
				
			    
						
		               
<section>
			<title value="A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:70.8pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Name and address of the manufacturer(s) of the biological active substance(s)"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:70.8pt;line-height:normal;page-break-after: avoid"></p><p class="Standard" style="line-height:normal"><span lang="DE-CH">Novartis Pharma AG</span></p><p class="Standard" style="line-height:normal"><span lang="DE-CH">Lichtstrasse 35</span></p><p class="Standard" style="line-height:normal"><span lang="DE-CH">4056 Basel</span></p><p class="MsoNormal" style="line-height:normal"><span lang="DE-CH">Switzerland</span></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Name and address of the manufacturer(s) responsible for batch release"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"></p><p class="Standard" style="line-height:normal">Novartis Pharma GmbH</p><p class="Standard" style="line-height:normal">Roonstrasse 25</p><p class="Standard" style="line-height:normal">90429 Nuremberg</p><p class="MsoNormal" style="line-height:normal">Germany</p><p class="MsoNormal" style="line-height:normal"> </p><p class="MsoNormal" style="line-height:normal"> </p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="C.      OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.05pt;line-height:normal;page-break-after: avoid"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="·Periodic safety update reports (PSURs)"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:28.35pt;line-height:normal;page-break-after: avoid"></p><p class="MsoNormal" style="margin-right:28.35pt;line-height:normal"><span lang="EN-GB">The requirements for submission of PSURs for this medicinal product are set out in the list of Union reference dates (EURD list) </span><span lang="EN-GB">provided for under Article 107c(7) of Directive 2001/83</span><span lang="EN-GB">/EC</span><span lang="EN-GB"> and </span><span lang="EN-GB">any subsequent updates published on the European medicines web‑portal.</span></p><p class="MsoNormal" style="margin-right:28.35pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">The marketing authorisation holder (MAH) shall submit the first PSUR for this product within 6 months following authorisation.</span></p><p class="MsoNormal" style="margin-right:-.05pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.05pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="D.      CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.05pt;line-height:normal;page-break-after: avoid"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="·Risk management plan (RMP)"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.05pt;line-height:normal;page-break-after: avoid"></p><p class="MsoNormal" style="margin-right:28.35pt;line-height:normal"><span lang="EN-GB">The </span><span lang="EN-GB">marketing</span><span lang="EN-GB"> authorisation holder (</span><span lang="EN-GB">MAH) shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the marketing authorisation and any agreed subsequent updates of the RMP.</span></p><p class="MsoNormal" style="margin-right:-.05pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">An updated RMP should be submitted:</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">At the request of the European Medicines Agency;</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.</span></p><p class="MsoNormal" style="margin-right:-.05pt;line-height:normal"></p><p class="Standard" style="margin-right:-.05pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="E.      SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="Standard" style="line-height:normal;page-break-after:avoid"></p><p class="Standard" style="margin-right:-.05pt;line-height:normal;page-break-after: avoid"><span lang="EN-GB">This being a conditional marketing authorisation and pursuant to Article 14a(4) of Regulation (EC) No 726/2004, the MAH shall complete, within the stated timeframe, the following measures:</span></p><p class="Standard" style="margin-right:-.05pt;line-height:normal;page-break-after: avoid"></p><table border="1" cellpadding="0" cellspacing="0" class="NormaleTabelle" style="border-collapse:collapse;border:none" width="100%"> <tr style="page-break-inside:avoid"> <td style="width:82.18%;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="82%"> <p class="Standard" style="margin-right:-.05pt;line-height:normal;page-break-after:   avoid"><b><span lang="EN-GB">Description</span></b></p> </td> <td style="width:17.82%;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="17%"> <p class="Standard" style="margin-right:-.05pt;line-height:normal;page-break-after:   avoid"><b><span lang="EN-GB">Due date</span></b></p> </td> </tr> <tr style="page-break-inside:avoid"> <td style="width:82.18%;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="82%"> <p class="TabletextrowsAgency" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>In   order to confirm the efficacy and safety of crizanlizumab, the MAH should   submit the results of the primary analysis of a phase III CSEG101A2301 study   of crizanlizumab with or without hydroxyurea/hydroxycarbamide in adolescent   and adult sickle cell disease patients with vaso-occlusive crises</span></p> </td> <td style="width:17.82%;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="17%"> <p class="TabletextrowsAgency" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>Clinical   study report primary analysis:</span></p> <p class="TabletextrowsAgency" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>December   2025</span></p> </td> </tr> <tr style="page-break-inside:avoid"> <td style="width:82.18%;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="82%"> <p class="TabletextrowsAgency" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>In   order to confirm the efficacy and safety of crizanlizumab, the MAH should   submit the final results of the phase II CSEG101A2202 study of   crizanlizumab with or without hydroxyurea/hydroxycarbamide in sickle cell   disease patients with vaso‑occlusive crisis.</span></p> </td> <td style="width:17.82%;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="17%"> <p class="TabletextrowsAgency" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>Clinical   study report:</span></p> <p class="TabletextrowsAgency" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>December   2025</span></p> </td> </tr> </table><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
	
</section>
							<!-- sections can repeat as necessary -->
						</Composition>
					</resource>
				</entry>
				
			</Bundle>
		</resource>
	</entry>
</Bundle>